Industry Supported Session Programmes


TUESDAY 16 MAY, 2017


ANTICOAGULATION CARE AND THE STROKE NEUROLOGIST: WHY NOAC REVERSAL MATTERS

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Boehringer Ingelheim

Tuesday 16 May, 12:45-14:15, Forum Hall

Introduction: Why Does (N)OAC Reversal Matter to Us?    

Stephen Davis, Australia (Co-Chair)

Optimizing Anticoagulation for Stroke Prevention

Ken Butcher, Canada

NOAC Reversal: What Features Matter for Stroke Neurologists?   

Richard Bernstein, USA

Idarucizumab in Ich: Interactive Cases            

Martin Grond, Germany

Idarucizumab and Thrombolysis in Ischaemic Stroke: Interactive Cases     

Hans-Christoph Diener, Germany (Co-chair)

Panel Discussion and Q&A   

Moderated by Stephen Davis (Australia) and Hans-Christoph Diener (Germany)



PCSK9 INHIBITORS: UNMET NEEDS AND NEW APPROACHES FOR LIPID MANAGEMENT

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Amgen

Tuesday 16 May, 12:45-14:15, South Hall

Chair: Pierre Amarenco, France

Welcome. Where Are We Now?

Pierre Amarenco, France

Stroke and Cholesterol Management: How Low Could We Go?

Pierre Amarenco, France

PCSK9 Inhibitors: The Story So Far

George Ntaios, Greece

PCSK9 Inhibitors: The Latest Studies

Gaetano De Ferrari, Italy

PCSK9 Inhibitors: Are There Any Neurocognitive Signals?

Pierre Amarenco, France

Panel Discussion

All

Meeting Summary and Close

Pierre Amarenco, France



ANTICOAGULATION WITH NOAC`S IN DAILY CLINICAL PRACTICE

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Bayer

Tuesday 16 May, 12:45-14:15, Meeting Hall I

Chair: Matthias Endres and Graeme Hankey

Opening

Matthias Endres (Germany) and Graeme Hankey (Australia)

Anticoagulation with NOAC – A New Chapter: Outcomes of RCT Reaffirmed in Daily Clinical Practice  

David Hargroves, UK  

Right Dose for The Right Patient

Hendrik Bonnemeier, Germany

Anticoagulation from The Perspective of Neurologists – A Practical Focus

Danilo Toni, Italy

Panel Discussion on Stage with Faculty

ALL

Closing

Graeme Hankey (Australia) and Matthias Endres (Germany)



ATRIAL FIBRILLATION, STROKE AND BLEEDING: WHAT DO I NEED TO KNOW?

SYMPOSIUM IS ORGANISED AND SUPPORTED BY MSD and Daiichi-Sankyo 

Tuesday 16 May, 12:45-14:15, Panorama Hall

Chair: Roland Veltkamp, UK

Welcome and Opening Remarks

Roland Veltkamp, UK

ESC Atrial Fibrillation Guidelines 2016 - The Perspective of a Cardiologist on Primary Stroke Prevention

Jonas Oldgren, Sweden

ESC Atrial Fibrillation Guidelines 2016 - The Perspective of a Neurologist on Secondary Stroke Prevention

László Szapáry, Hungary

Emerging Evidence in Secondary Stroke Prevention

Florian Masuhr, Germany

Intracranial Hemorrhage – The Most Feared Complication of Anticoagulation Therapy

Roland Veltkamp, UK

Round Table and Q&A

Florian Masuhr (Germany), Jonas Oldgren (Sweden) and László Szapáry (Hungary)



DIFFERENTIAL DIAGNOSIS FOR STROKE: DON'T MISS OUT FABRY DISEASE

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Shire

Tuesday 16 May, 12:45-14:15, Meeting Hall IV

Introduction

Ricardo Reisin, Argentina (Co-chair) and C. Enzinger, Austria (Co-chair)

Vasculopathy and Cerebrovascular Complications: Reasons for Stroke in Fabry Disease

Ricardo Reisin, Argentina

Who to Screen for Fabry Disease?

Tobias Böttcher, Germany

Neuroimaging in Diagnosing Rare Neurological Diseases

Christian Enzinger, Austria

What the Heart Can Tell the Brain in Fabry Disease?

Ales Linhart, Czech Republic

Panel Q&A

All speakers

Closing Remarks

Ricardo Reisin, Argentina (Co-chair) and C. Enzinger, Austria (Co-chair)



WEDNESDAY 17 MAY, 2017

 

LEAVING A LEGACY IN STROKE CARE IN EUROPE: A COMMUNITY OF DEDICATED PROFESSIONALS IS CHANGING THE FACE OF STROKE IN EUROPE.

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Boehringer Ingelheim

Wednesday 17 May, 12:45-14:15, Forum Hall

Chairs: Valeria Caso (Italy) and Robert Mikulik (Czech Republic)

Angels Initiative – Update

Valeria Caso, Italy

Reducing in-hospital delays: clinical cases and simulation education

Risto Roine and Pauli Ylikotila, Finland. Presentation of case with door-to-needle time 6 minutes

Miro Brozman, Slovakia. Presentation of case with door-to-needle time 6 minutes 50 seconds

Robert Mikulik, Czech Republic. Presentation of simulation training to shorten door-to-needle time

Expansion of the Quality in Acute Stroke Care (QASC) into Europe

Sandy Middleton, Australia

NOR-TEST: New insights into thrombolysis

Lars Thomassen, Norway

Panel discussion

All



STROKE TREATMENT: FROM ONSET TO REHABILITATION

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Medtronic

Wednesday 17 May, 12:45-14:15, Meeting Hall V 

Chair : Urs Fischer, Switzerland: Meeting Summary and close

Moderator: Urs Fischer, Switzerland

Regional pre-hospital organization: the catalan model

Antoni Dávalos, Spain

SWIFT DIRECT "In-hospital stroke treatment"

Jan Gralla, Switzerland

AF Detection Using Insertable Cardiac Monitors : A Call For Neurologists

Krassen Nedeltchev, Switzerland

Stroke and Spasticity: Stroke & spasticity : what is Targeted drug delivery?

Leopold Saltuari, Austria

Panel Discussion and Q&A


 

STROKE MANAGEMENT AND PREVENTION IN AF: STATE OF THE ART IN 2017

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Pfizer

Wednesday 17 May, 12:45-14:15, Meeting Hall I

Practical Challenges and Questions in Stroke Management in AF

Hans-Christoph Diener, Germany

Optimizing Stroke Prevention in AF: Findings from Clinical Practice to Complement Randomized Trials Data

Stefan Hohnloser, Germany

Acute Stroke Management in The Emergency Room

Didier Leys, France

Anticoagulation After an Acute Stroke

Hans-Christoph Diener, Germany

Secondary Stroke Prevention in AF: How Can NOACs Improve Patient Care?

Carlos Molina, Spain

Collating Evidence, Experience and Expert Insight

Hans-Christoph Diener, Germany


Penumbra SYMPOSIUM AT ESOC 2017

Wednesday 17 May, 12:45-14:15, Panorama Hall

Moderator: Paola Santalucia

Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy

Outcomes of Mechanical Thrombectomy Using the ADAPT Technique in a Large Real Life Multi-Centre Series

Bertrand Lapergue,

Hôpital Foch, Suresnes, France

Initial Experience of the 3MAX Reperfusion Catheter as Frontline ADAPT Therapy to

Treat Distal Occlusions in AIS

Jens Altenbernd

Knappschaftskrankenhaus, Recklinghausen, Germany

Cost Effectiveness Analysis Using the ADAPT Technique

Kyriakos Lobotesis

Charing Cross Hospital, London, UK


THE EVOLUTION OF STROKE TREATMENT AND FUTURE DIRECTIONS

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Stryker

Wednesday 17 May, 12:45-14:15, Meeting Hall IV

The importance of Real World data in stroke
Priya Gaiha, USA

Mechanical Thrombectomy with stent-retriever: Analysis of 1,539 patients from the TREVO Registry
Antonin Krajina, Czech Republic

Thrombectomy REVascularization of large vessel Occlusion (TREVO Retriever Registry): Clinical outcomes beyond 6 hours
Raul Nogueira, USA

Mechanical Thrombectomy is cost-effective
Sanjeev Nayak, UK

STREAM: Multidisciplinary stroke team training improves results
Waltraud Pfeilschifter, Germany


THURSDAY 18 MAY, 2017

 

STROKE RECOVERY - PHARMACOLOGICAL TREATMENT CONCEPTS IN THE ACUTE AND SUB-ACUTE PHASE

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Ever Neuro Pharma

Thursday 18 May, 12:15-13:45, Meeting Hall I

Chairmen: Michael Chopp (USA) and Michael Brainin (Austria)

Special Acknowledgement: ESO-EAST - Achievements 2016 and Future Initiatives

Robert Mikulik, Czech Republic

New Rigorous Preclinical Trials of Cerebrolysin for Stroke

Michael Chopp, USA

Cerebrolysin's Evidence in Acute Stroke - A Clinical Review

Milan Vosko, Austria

Challenges and Opportunities in Motor Recovery

Dafin Muresanu, Romania

Stroke and Cognition

Michael Brainin, Austria


RETHINKING POST-STROKE REHABILITATION & THE ROLE OF VR 

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Mindmaze

Thursday 18 May, 12:15-13:15, Meeting Hall IV

Moderator:  Valeria Caso, Italy 

Neurorehabilitation and Stroke. Towards Patient Tailored Treatment

Friedhelm Christoph Hummel, Switzerland

Upper Limb Rehabilitation: Lessons from the Past and Perspectives for the Future

Nick Ward, UK

The MOVE-Rehab Study: MindMotionPRO Plus Standard Practice Versus Standard Practice in Early Post-stroke Upper-limb Rehabilitation

Jesse Dawson, UK

VR-based Neuro Rehabilitation: Vision for the MindMotion Product Family

Andrea Serino, Switzerland 


Keep Me Updated